|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
Endocarditis |
|
Epididymitis |
|
Infection, biliary tact |
|
Infection, bone |
|
Infection, genital tract |
|
Infection, joint |
|
Infection, respiratory tract |
|
Infection, skin and skin structure |
|
Infection, urinary tract |
|
Prophylaxis, surgical |
|
Prostatitis |
|
Septicemia |
| |
|
|
SIDE EFFECTS:
|
|
thrombocytopenia |
|
abdominal pain |
|
acute generalized exanthematous pustulosis (AGEP) |
|
anaphylactoid reactions |
|
anorexia |
|
candidiasis |
|
diarrhea |
|
injection site reaction |
|
interstitial nephritis |
|
leukopenia |
|
maculopapular rash |
|
nausea/vomiting |
|
neutropenia |
|
phlebitis |
|
pruritus |
|
pruritus ani |
|
seizures |
|
Stevens-Johnson syndrome |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
breast-feeding |
|
coagulopathy |
|
colitis |
|
GI disease |
|
intramuscular injections |
|
penicillin hypersensitivity |
|
pregnancy |
|
renal disease |
|
renal impairment |
|
|
ADULT DOSE:
|
|
[Endocarditis, prophylaxis] -Intramuscular or intravenous, 1 gram (base) one-half hour prior to the start of surgery .
Perioperative prophylaxis-Intramuscular or intravenous, 1 gram (base) one-half to one hour prior to the start of surgery; 500 mg to 1 gram during surgery; and 500 mg to 1 gram every six to eight hours following surgery for up to twenty-four hours .
Pneumonia, pneumococcal-Intramuscular or intravenous, 500 mg (base) every twelve hours .
Urinary tract infections, acute, uncomplicated -Intramuscular or intravenous, 1 gram (base) every twelve hours .
For all other infections-Mild: Intramuscular or intravenous, 250 to 500 mg (base) every eight hours .
Moderate to severe: Intramuscular or intravenous, 500 mg to 1 gram (base) every six to eight hours .
Severe to life-threatening: Intramuscular or intravenous, 1 to 1.5 grams (base) every six hours .
Note: Adults with renal function impairment may require a reduction in dose .
See Cefazolin Injection USP . |
|
MAXIMUM ADULT DOSE:
|
|
6 grams (base) per day; however, doses of up to 12 grams per day have been used in rare instances .
|
|
PEDIATRIC DOSE:
|
|
[Endocarditis, prophylaxis] -Intramuscular or intravenous, 25 mg (base) per kg of body weight one-half hour prior to the start of surgery .
For all other infections-Infants and children 1 month of age and older: Intramuscular or intravenous, 6.25 to 25 mg (base) per kg of body weight every six hours; or 8.3 to 33.3 mg per kg of body weight every eight hours .
Neonates and infants up to 1 month of age: Intravenous infusion, 20 mg (base) per kg of body weight every eight to twelve hours .
Note: Children with renal function impairment may require a reduction in dose .
See Cefazolin Injection USP . |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
1 gram (base) for prophylaxis of bacterial endocarditis .
|
|
ELDERLY DOSE:
|
|
[Endocarditis, prophylaxis] -Intravenous infusion, 1 gram (base) one-half hour prior to the start of surgery .
Perioperative prophylaxis-Intravenous infusion, 1 gram (base) one-half to one hour prior to the start of surgery; 500 mg to 1 gram during surgery; and 500 mg to 1 gram every six to eight hours following surgery for up to twenty-four hours .
Pneumonia, pneumococcal-Intravenous infusion, 500 mg (base) every twelve hours .
Urinary tract infections, acute, uncomplicated -Intravenous infusion, 1 gram (base) every twelve hours .
For all other infections-Mild: Intravenous infusion, 250 to 500 mg (base) every eight hours .
Moderate to severe: Intravenous infusion, 500 mg to 1 gram (base) every six to eight hours .
Severe to life-threatening: Intravenous infusion, 1 to 1.5 grams (base) every six hours .
Note: After an initial loading dose appropriate to the severity of the infection, adults with impaired renal function may require a reduction in dose as follows :
Creatinine clearance (mL/min)/(mL/sec) Dose (base)
³ 55/0.92 See Usual adult and adolescent dose
35-54/0.58-0.9 Full dose every 8 hours or less frequently
11-34/0.18-0.57 1/2usual dose every 12 hours
£ 10/0.17 1/2usual dose every 18-24 hours |
|
|
|
|
|